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Background: In recent years, the use of chest ultrasonography to detect lung water has received growing
attention in clinical research. Estimation of the number of B-lines using lung ultrasound is now a standard method
for the evaluation of pulmonary congestion. In the present study, we examined the relation between the number
of B-lines and clinical parameters in hemodialysis patients.
Methods: A total of 49 consecutive patients receiving maintenance hemodialysis were enrolled in this study. Lung
ultrasound was performed using Vscan® (GE Healthcare, Japan). Bilateral scanning of the anterior and lateral chest
walls was performed with the patient in a supine position just after the start of the hemodialysis therapy. The total
number of B-lines was estimated. We investigated the relationships between the number of B-lines and other
clinical parameters.
Results: Patient heart rate and the serum log [NT-proBNP] level were positively correlated (P = 0.009 and 0.003,
respectively), and body weight and the serum albumin and creatinine level were negatively correlated with the
number of B-lines (P = 0.023, 0.001, and 0.011, respectively).
Conclusions: The number of B-lines was positively correlated with the serum N-terminal pro-brain natriuretic
peptide level. Lung ultrasound can quantify lung edema. Body weight and the serum albumin and creatinine level
were negatively correlated with the number of B-lines. Careful attention to the presence of pulmonary edema is
needed in patients with a low body weight and a low serum albumin and creatinine level.
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Chronic fluid overloading frequently occurs in hemodialysis
patients, so one of the major targets of hemodialysis ther-
apy is to maintain a normal extracellular volume status.
Preventing volume overload is a central recommendation
when it comes to nephrology best-practice guidelines for
dialysis patients [1], as this goal is directly associated with
hypertension, increased arterial stiffness, left ventricular
hypertrophy, heart failure, and ultimately higher rates of
mortality and morbidity [2].* Correspondence: sotsubo@hb.tp1.jp
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(http://creativecommons.org/publicdomain/zeTo estimate the volume status, several methods have
been proposed, such as evaluating the natriuretic peptide
levels [3, 4], the dimensions and collapsibility of the
inferior vena cava [5], chest X-ray signs, and bioelectrical
impedance analysis techniques [6, 7]. However, each of
these methods has significant theoretical and practical
limitations.
In recent years, the use of chest ultrasonography to
detect lung water has received growing attention in clin-
ical research focused on intensive care patients [8] and pa-
tients with heart failure [9]. The most commonly observed
finding was a comet tail artifact fanning out from the
lung-wall interface and spreading upwards to the edge of
the screen, previously named a “B-line” (Fig. 1) [10]. In pa-
tients with heart failure, the number of B-lines was corre-
lated with the degree of extravascular lung water [11], andle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Fig. 1 B-lines: comet tail artifacts fanning out from the lung-wall interface and spreading upwards to the edge of the screen
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cacy of treatment [1]. Previous studies have also shown
that lung ultrasound can detect extravascular lung
water and can be used to show a significant reduction
after a dialytic session (both hemodialysis and periton-
eal dialysis) [12–15]. Existing data suggest that lung
ultrasound characteristics might be suitable for asses-
sing the ideal body weight in hemodialysis patients,
since this technique is simple, inexpensive, nonionizing,
and can easily be performed at the patient’s bedside
[16, 17].
Consequently, estimation of the number of B-lines
using lung ultrasound is now a standard method for the
evaluation of pulmonary congestion [18]. In the present
study, we examined the relation between the number of
B-lines and clinical parameters in hemodialysis patients.
Methods
The proportion of hospitalization for acute heart failure in
hemodialysis patients was significantly higher on Monday
(approximately 1/3) compared with other days [19]. So we
selected patients who underwent hemodialysis therapy
on Monday (the first day after weekend interval). A
total of 49 consecutive patients receiving maintenance
hemodialysis at Sekikawa Hospital on Monday were
enrolled in this study. Informed consents were ob-
tained in all patients.
Clinical data including age, sex, duration of hemodialysis
therapy, presence of diabetes mellitus and/or hypertension
and/or dyslipidemia complications, use of antihypertensive
drug, history of coronary artery disease, and the results of
biological examinations were collected from the patient’s
clinical records. Hypertension was defined as a systolicblood pressure of 140 mmHg or higher, a diastolic blood
pressure of 90 mmHg or higher, and/or the current use of
antihypertensive drugs. Diabetes mellitus was defined as a
fasting glucose level ≥126 mg/dL, a nonfasting glucose
level ≥200 mg/dL, or the use of medication. Dyslipidemia
was defined as a low-density lipoprotein-cholesterol level
≥140 mg/dL, a high-density lipoprotein-cholesterol level
<40 mg/dL, a triglyceride level ≥150 mg/dL, or the use of
medication.
A peripheral blood sample was obtained before
hemodialysis during the first session of the week. The
serum N-terminal pro-brain natriuretic peptide (NT-
proBNP) level in the pre-dialysis blood sample was mea-
sured using an electrochemiluminescence immunoassay
on an Elecsys platform (Roche, Basel, Switzerland).
Lung ultrasound was performed at the first session of
the week, the same time of peripheral blood sample prep-
aration, using Vscan® (GE Healthcare, Japan), a hand-held
ultrasound device with a wide-bandwidth phased-array
probe (1.7–3.5 MHz) [20, 21]. Bilateral scanning of the
anterior and lateral chest walls was performed with the
patient in a supine position just after the start of the
hemodialysis therapy. An intercostal scan with maximum
extension of the visual pleural line was performed. The
chest wall was divided into eight areas (two anterior and
two lateral areas per side), and two scan was obtained for
each area [22–26]. The anterior zone of the chest wall was
designated from the sternum to the anterior axillary line
and was then divided into upper and lower halves (from
the clavicle to the third intercostal spaces and from the
third space to the diaphragm). The lateral zone was posi-
tioned from the anterior axillary line to the posterior axil-
lary line and was also divided into the upper and lower
Table 1 Background characteristics of the study participants
Characteristic Quantity
Gender (M/F) 24/25
Age (year) 74.5 ± 11.2
Duration of HD (year) 3.4 (2.1–7.2)
Primary cause of ESKD, n (%)
Chronic glomerulonephritis 8 (16.3)
Diabetic nephropathy 22 (44.9)
Nephrosclerosis 10 (20.4)
Unknown and others 9 (18.4)
Hypertension, n (%) 41 (83.7)
Diabetes mellitus, n (%) 21 (42.9)
Dyslipidemia, n (%) 10 (20.4)
Atrial fibrillation, n (%) 6 (12.2)
Use of antihypertensive drug, n (%) 38 (77.6)




Arteriovenous fistula 43 (87.8)
Arteriovenous graft 2 (4.1)
Subcutaneously fixed superficial artery 2 (4.1)
Venous catheter 2 (4.1)
Body weight (kg) 52.7 ± 11.5
Systolic blood pressure (mmHg) 141 ± 26
Diastolic blood pressure (mmHg) 73 ± 16
Heart rate (beat/minute) 75 ± 13
Ejection fraction (%) 60 ± 12
B-lines (number) 10.8 ± 4.6
Mean ± SD, median (interquartile range: IQR)
HD hemodialysis, ESKD end-stage kidney disease, PCI percutaneous coronary
intervention, CABG coronary artery bypass grafting
Table 2 Background characteristics of laboratory data
Characteristic Quantity
Albumin (g/dL) 3.2 ± 0.5
Urea nitrogen (mg/dL) 51.8 ± 19.0
Creatinine (mg/dL) 7.57 ± 2.41
Sodium (mEq/L) 137 ± 4
C-reactive protein (mg/dL) 0.26 (0.10–0.91)
Hemoglobin (g/dL) 10.4 ± 1.2
NT-proBNP (pg/mL) 13,650 (4355–28,011)
log [NT-ProBNP (pg/mL)] 9.26 ± 1.33
Mean ± SD, median (interquartile range: IQR)
NT-proBNP N-terminal pro-brain natriuretic peptide
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peripheral blood sample, attempted to detect comet tail
artifacts fanning out from the lung-wall interface and
spreading to the edge of the screen, which were previously
named B-lines (Additional file 1: Movie S1) [23, 24]. The
total number of B-lines was estimated. Echocardiographic
measurements were obtained at the same time and left
ventricular ejection fraction (LVEF) was estimated.
We investigated the relationships between the number
of B-lines and other clinical parameters. This study was
conducted in accordance with the principles of the Declar-
ation of Helsinki and was permitted by the research ethics
committee of Sekikawa Hospital (Approved No. H2705).
The data were expressed as the means ± SD or median
(interquartile range, IQR). A simple and multivariate re-
gression analysis was used to examine the relationship be-
tween two continuous variables. Because of the skewed
distribution of the NT-proBNP levels, the data were nor-
malized using a logarithmic transformation for further
statistical analysis. All the statistical calculations were per-
formed using JMP 5.1 software. P values less than 0.05
were considered statistically significant.
Results
The patient background characteristics are shown in
Table 1. The mean age was 74.5 ± 11.2 years. Elderly pa-
tients were common in this study. Diabetic nephropathy
was the major cause of end-stage kidney disease. Hyper-
tension, diabetes mellitus, and dyslipidemia were present
in 83.7, 42.9, and 20.4% of the study participants, respect-
ively. The mean number of B-lines was 10.8 ± 4.6. The re-
sults of the biochemistry analyses, including the NT-
proBNP level, are shown in Table 2. The serum albumin
level was relatively low (3.2 ± 0.5 g/dL), and the serum NT-
proBNP level was relatively high (13,404 (4355–28,011)
pg/mL) among the study participants.
Table 3 shows the relationships between the number of
B-lines and other clinical parameters. Heart rate and the
serum log [NT-proBNP] level were positively correlated
(P = 0.009 and 0.003, respectively), and body weight and
the serum albumin and creatinine levels were negatively
correlated with the number of B-lines (P = 0.023, 0.001
and 0.011, respectively). Patient age tended to be posi-
tively associate with the number of B-lines (P = 0.055).
LVEF tended to negatively relate to the number of B-
lines (P = 0.056). In multivariate analysis including body
weight and heart rate and the serum albumin, creatin-
ine, and log [NT-proBNP] levels, only the serum log
[NT-proBNP] level remained significant relation to the
number of B-lines (P = 0.014).
Discussion
We showed that the number of B-lines was positively
correlated with heart rate and the serum NT-proBNP
Table 3 The relationship between the number of B-lines and
other clinical parameters
r P value
Age (years) 0.276 0.055
Duration of HD (year) 0.026 0.576
Body weight (kg) −0.325 0.023
Systolic blood pressure (mmHg) −0.103 0.479
Diastolic blood pressure (mmHg) 0.013 0.928
Heart rate (beat/minute) 0.371 0.009
Ejection fraction (%) −0.275 0.056
Albumin (g/dL) −0.444 0.001
Urea nitrogen (mg/dL) −0.159 0.276
Creatinine (mg/dL) −0.360 0.011
Sodium (mEq/L) −0.248 0.085
C-reactive protein (mg/dL) 0.063 0.666
Hemoglobin (g/dL) −0.197 0.175
NT-ProBNP 0.523 <0.001
log [NT-ProBNP] 0.447 0.002
HD hemodialysis, NT-proBNP N-terminal pro-brain natriuretic peptide
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weight and the serum albumin and creatinine level.
Lung ultrasound assessments of extravascular lung
water based on the number of B-lines provide an
excellent diagnostic alternative, expanding the already
established role of transthoracic echocardiography for
patients with heart failure [2, 27–29]. Bedetti et al.
compared lung ultrasound information obtained by ex-
perienced echocardiologists and by inexperienced echo-
cardiographer with very limited (30') dedicated training
on B-lines assessment and reveal, there was a signifi-
cant, tight correlation (r = 0.958, p < 0.001) between the
two observations in the same patient [30]. B-lines can
be evaluated anywhere (including extreme environmen-
tal conditions using pocket-sized instruments to detect
high-altitude pulmonary edema), anytime (during dialy-
sis), by anyone (even a novice sonographer after 1 h of
training), and on anybody (since the chest acoustic
window usually remains patent even when an echocar-
diography is not feasible) [18]. The pre-dialysis number
of B-lines significantly correlated with a whole body
bioimpedance spectroscopy device-derived extracellular
water in hemodialysis patients [31]. Vitturi et al. inves-
tigated lung and bioimpedance spectroscopy results im-
mediately before and after dialysis and reported that a
reduction in the number of B-lines was correlated with
fluid loss as a result of hemodialysis, conforming that
lung ultrasound can identify extravascular lung water.
The number of post-dialysis B-lines is correlated with
the residual weight assessed using bioimpedance, sug-
gesting a role for ultrasound in the management ofhemodialysis patients [32]. The serum NT-proBNP level is
influenced not only by heart function but also by the vol-
ume status. Among nondialysis patients, lung congestion
was correlated with the NT-proBNP level [22]. Natriuretic
peptides may directly enhance capillary permeability, an
effect that may explain the association in addition to filling
pressure alone [33]. In this study, we also showed a posi-
tive and independent relationship between the number of
B-lines and the serum NT-proBNP level in hemodialysis
patients.
We also showed that the number of B-lines was posi-
tively correlated with heart rate and negatively correlated
with body weight and the serum albumin and creatinine
level. Volume overload results in lung congestion and
also activates the sympathetic nervous system which in-
creases the heart rate. Hypoalbuminemia is common in
heart failure patients [34, 35]. Two mechanisms have
been proposed to explain the relationship between hypo-
albuminemia and congestion. On the one hand, an in-
crease in vascular permeability mediated by an increase
in hydrostatic venous pressure may increase the transca-
pillary escape rate of albumin from the intravascular to
the extravascular space [36]; on the other hand, it is pos-
sible that intestinal congestion favors albumin enteric
losses [37]. It is well documented that a decrease in the
body mass index is correlated with an increased mortal-
ity rate in patients with heart failure [38, 39]. Serum
level of albumin was positively related to body weight in
our study participants (r = 0.332, P = 0.020, data not
shown). Both hypoalbuminemia and body weight loss
are result of malnutrition. That may be the reason of
the relationship between B-lines and body weight.
Giuseppe et al. previously reported that physical func-
tioning was inversely associated with the number of B-
lines and patient age and was positively associated with
the serum albumin level [40]. In our study, patient age
tended to be positively associate with the number of
B-lines (P = 0.055). In elderly patients, hypoalbuminemia,
body weight loss (which results in reduction of serum
creatinine level), and a low level of physical functioning
are known to affect each other. Under such conditions,
lung congestion, which can be detected by lung ultra-
sound as B-lines, should be considered.
Left ventricular systolic dysfunction may cause over-
hydration which result in lung congestion. On the other
hand, overhydration may cause lung congestion and in-
crease venous return volume and ventricular filling,
thereby increase the stroke volume by the Frank-Starling
mechanism when LVEF is preserved. There are conflicting
result about the relationship between the number of B-
lines and LVEF. Mallamaci et al. [12] used this technique
in a population of 75 hemodialysis patients and showed
the number of B-lines was negatively associated with an
LVEF. But in other study, Siriopol et al. reported the
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ferences are most certainly the result of differences in
study populations. In Siriopol et al.’s study, the patients
(being younger and possibly with less comorbidities) had a
preserved left ventricular systolic function (only 6.3% of
the patients had an LVEF of <50%) [31]. In our study, 11
(22.4%) of the patients had an LVEF of <50%. In
hemodialysis patients, the relationship between hydration
status, B-lines, and left ventricular systolic function is
complex. Accordingly, additional investigation will be
needed to clarify the mechanism underlying the associ-
ation between overhydration and B-lines in hemodialysis
patients with a preserved or reduced LVEF.
Our study had some limitations. The sample size was
relatively small, and the study was performed at a single
institution. B-lines represent the volume status of extra-
vascular lung water. There are some markers of intravas-
cular volume such as cardiothoracic ratio, inferior vena
cava, and serum level of atrial natriuretic peptide. Bioim-
pedance spectroscopy device enables to derive the extra-
cellular water and intracellular water. But we did not
have such data, so we could not discuss the relation be-
tween these markers. Another limitation of this study
was that the investigator who performed lung ultrasound
was not blind for the clinical information of the patients
such as age, gender, or clinical diagnosis. In addition, the
limitations of lung ultrasound are essentially patient-
dependent. Obese patients may be more difficult to
examine because of the thickness of their ribcages and
soft tissues. Furthermore, the cross-sectional design pre-
vented us from making any conclusions regarding the ef-
fects of treatment. The study participants were also
relatively old, their serum albumin levels were relatively
low, and their serum NT-proBNP levels were relatively
high because of the specificity of our institution.Conclusions
The number of B-lines was positively correlated with the
serum NT-proBNP level. Lung ultrasound can quantify
lung edema noninvasively in real time and in a
radiation-free manner, enabling the direct imaging of
extravascular lung water. Patient age tended to be posi-
tively correlated and the body weight and the serum al-
bumin and creatinine levels were negatively correlated
with the number of B-lines. Careful attention to the
presence of pulmonary edema is needed in elderly pa-
tients with a low body weight and a low serum albumin
and creatinine level.Additional file
Additional file 1: Movie S1 B-lines detected by lung ultrasound using
Vscan® (GE Healthcare, Japan). (mp4 2009 kb)Abbreviations
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